AEX 5
Alternative Names: AEX-5Latest Information Update: 12 Mar 2024
At a glance
- Originator Aexon Labs
- Class
- Mechanism of Action Cathepsin inhibitors; Dopamine uptake inhibitors; Orexin receptor type 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders
Most Recent Events
- 26 Feb 2024 Early research in CNS disorders in USA (unspecified route) (Aexon Labs pipeline, February 2024)